Foghorn Therapeutics (FHTX) Other Accumulated Expenses (2020 - 2026)

Foghorn Therapeutics' Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $437000.0 for Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 16.92% year-over-year to $437000.0; the TTM figure through Mar 2026 stood at $437000.0 (down 16.92% YoY), while the FY2025 annual figure was $400000.0, up 39900.0% from the prior year.
• Other Accumulated Expenses was $437000.0 for Q1 2026 at Foghorn Therapeutics, up from $400000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $526000.0 in Q1 2025 to a low of $1000.0 in Q4 2024.
• Historically, Other Accumulated Expenses has averaged $269625.0 across 5 years, with a median of $286500.0 in 2022.
• The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses plunged 97.22% in 2024, then jumped 39900.0% in 2025.
• A 5-year view of Other Accumulated Expenses shows it stood at $318000.0 in 2022, then sank by 88.68% to $36000.0 in 2023, then slumped by 97.22% to $1000.0 in 2024, then surged by 39900.0% to $400000.0 in 2025, then gained by 9.25% to $437000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $437000.0 (Q1 2026), $400000.0 (Q4 2025), and $396000.0 (Q3 2025), per Business Quant data.